Mobile

A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®)-Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects with Choroidal Neovasularization (CNV) Associated with Age-Relate...

Update Il y a 4 ans
Reference: EUCTR2009-017435-18

A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®)-Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects with Choroidal Neovasularization (CNV) Associated with Age-Related Macular Degeneration (AMD)

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the safety and efficacy of treatment with WST11 (Stakel®) and Vascular-Targeted Photodynamic (VTP) therapy.

Inclusion criteria

  • Age associated Macular Degeneration

Links